Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Wei-dong Pei"'
Publikováno v:
Cardiovascular Therapeutics. 31:60-64
SUMMARY Introduction: Metformin is one of the most commonly prescribed antihyperglycemic agents for the treatment of type 2 diabetes. However, little is known about the effect of metformin on no-reflow in diabetic patients. Aim: In this study, we inv
Publikováno v:
American Journal of Cardiovascular Drugs. 9:81-89
An association between admission plasma glucose levels and an increased risk of no-reflow has been well documented. Although HMG-CoA reductase inhibitor (statin) therapy can reduce no-reflow, little is known about its effect on no-reflow in patients
Publikováno v:
Acta Cardiologica. 63:355-359
UNLABELLED It has been verified that adenosine can attenuate myocardial no-reflow. However, the effects of adenosine on adenosine triphosphate-sensitive K+ (KATP) channel and endothelin-1 (ET-1) are unknown. METHODS Forty mini-swines were randomized
Publikováno v:
Scientia Pharmaceutica
Volume 76
Issue 2
Pages 171-184
Volume 76
Issue 2
Pages 171-184
It has been verified that glycoprotein IIb/IIIa inhibitor tirofiban can attenuate myocardial no-reflow. Myocardial no-reflow has been associated with alterations in endothelial junctions. In addition, ET-1 is an important mechanism for myocardial no-
Autor:
Yongjian Wu, Jue Chen, Hai-Bo Liu, Jun Dai, Jian-Jun Li, Sheng Kang, Xue-Wen Qin, Shubin Qiao, Runlin Gao, Bo Xu, Yuejin Yang, Ji-Lin Chen, Wei-Dong Pei, Shi-Jie You, Min Yao
Publikováno v:
Chinese Medical Journal. 120:1868-1873
BACKGROUND The sirolimus and paclitaxel distribution patterns and tissue residence time may be modified in atherosclerotic lesions for patients with diabetes, and the biological mechanisms of action for these agents differ significantly. Previous cli
Autor:
Yu-Hua Sun, Yue-Jin Yang, Yuan‐Hui Zhang, Jing-lin Zhao, Wei-Dong Pei, Run-Lin Gao, Ji‐Lin Chen
Publikováno v:
Clinical Cardiology. 30:130-134
Background In animal models, pretreatment with angiotensin-converting enzyme inhibitor (ACEI) can reduce no-reflow. In the present study, we investigated whether pretreatment with ACEI may prevent no-reflow in patients who underwent primary coronary
Smoking increases the risk of coronary artery disease in Chinese with Chlamydia pneumoniae infection
Publikováno v:
International Journal of Cardiology. 97:199-203
Background: The infection with Chlamydia pneumoniae (Cp) has been claimed to associate with coronary artery disease (CAD). However, the seroepidemiological study of association between Cp infection and CAD still remains a source of controversy. The a
Publikováno v:
Recent Advances in Computer Science and Information Engineering ISBN: 9783642257773
A class of dynamic complex network evolving models with multi-triangular structure is given. By utilizing the mean-field theory, it is proved that the models have the probability of power-law degree distribution with large average coefficient cluster
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3fbeb8a67ff207a73a0435b1e8ad8a2
https://doi.org/10.1007/978-3-642-25778-0_105
https://doi.org/10.1007/978-3-642-25778-0_105
Autor:
Jing-Lin, Zhao, Chao-Mei, Fan, Yue-Jin, Yang, Shi-Jie, You, Xin, Gao, Qiong, Zhou, Wei-Dong, Pei
Publikováno v:
Cardiovascular therapeutics. 31(1)
Metformin is one of the most commonly prescribed antihyperglycemic agents for the treatment of type 2 diabetes. However, little is known about the effect of metformin on no-reflow in diabetic patients.In this study, we investigated retrospectively wh
Publikováno v:
2010 International Conference on Multimedia Technology.
To enable intelligent agents to effectively deal with emotion,the formal description of emotional agent based on the LOBA logic and axioms derived are described. The model provide theoretical foundation for the construction of emotional rule base t